A new study says that researchers at Israel’s Tel Aviv University have reported that antibodies to RBD have been identified in patients recovering from Kovid-19. Strong and long-term immunity is also found in some people already treated for COVID 19 successfully.
This study has been done about antibodies proving to be important in combating coronavirus (COVID-19). This showed that most corona victims may have natural antibodies. This study supports the use of multiple antibodies simultaneously in the prevention and treatment of corona infection.
This is related to RBD
According to the researchers, the antibody specifically targets the receptor-binding domain (RBD) of the spike protein of the corona. This virus enters human cells through this protein. To control this virus, controlling the spike protein is considered an essential component.
Researchers at Israel’s Tel Aviv University have reported that antibodies to RBD have been identified in patients recovering from Kovid-19. have strong and long-lasting immunity has also been found in some cured people.
Blood cells play an important role in defense of germs attack
According to the study published in the journal PLOS Pathogen, this has just been concluded based on research conducted on eight people suffering from corona and ten patients with mild symptoms. One and a half months after recovering from an infection, B-cell response was noticed in the samples of these people. The B cells (cells) of the immune system play an important role in preventing the attack of germs.
